| 2020 |
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. |
Lancet (London, England) |
1961 |
32888407 |
| 2014 |
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study. |
Blood |
528 |
24591201 |
| 2012 |
RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. |
Cell |
384 |
22579284 |
| 2015 |
Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. |
Nature genetics |
383 |
25848748 |
| 2004 |
Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. |
Annals of hematology |
378 |
15480663 |
| 2009 |
The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. |
Cell |
335 |
19269368 |
| 2008 |
RTEL1 maintains genomic stability by suppressing homologous recombination. |
Cell |
307 |
18957201 |
| 2022 |
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL. |
Nature |
291 |
36045296 |
| 2004 |
Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. |
Cell |
275 |
15210109 |
| 2013 |
RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication. |
Science (New York, N.Y.) |
180 |
24115439 |
| 2015 |
Rare variants in RTEL1 are associated with familial interstitial pneumonia. |
American journal of respiratory and critical care medicine |
156 |
25607374 |
| 2024 |
Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001. |
Blood |
150 |
37890149 |
| 2009 |
nhl-2 Modulates microRNA activity in Caenorhabditis elegans. |
Cell |
148 |
19269369 |
| 2013 |
Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability. |
Human molecular genetics |
144 |
23591994 |
| 2010 |
RTEL-1 enforces meiotic crossover interference and homeostasis. |
Science (New York, N.Y.) |
143 |
20203049 |
| 2015 |
TRF2 recruits RTEL1 to telomeres in S phase to promote t-loop unwinding. |
Molecular cell |
134 |
25620558 |
| 2015 |
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis. |
The European respiratory journal |
133 |
26022962 |
| 2024 |
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study. |
The Lancet. Haematology |
127 |
38889737 |
| 2013 |
Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome. |
Proceedings of the National Academy of Sciences of the United States of America |
123 |
23959892 |
| 2013 |
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. |
PLoS genetics |
110 |
24009516 |
| 2024 |
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial. |
Leukemia |
109 |
39322711 |
| 2014 |
RTEL1: functions of a disease-associated helicase. |
Trends in cell biology |
105 |
24582487 |
| 2012 |
The mammalian TRIM-NHL protein TRIM71/LIN-41 is a repressor of mRNA function. |
Nucleic acids research |
104 |
23125361 |
| 2012 |
RTEL1 contributes to DNA replication and repair and telomere maintenance. |
Molecular biology of the cell |
99 |
22593209 |
| 2010 |
Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
97 |
20368557 |
| 2010 |
RTEL1: an essential helicase for telomere maintenance and the regulation of homologous recombination. |
Nucleic acids research |
88 |
21097466 |
| 2017 |
Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL. |
Leukemia & lymphoma |
86 |
29058502 |
| 2005 |
Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis. |
Oncogene |
83 |
16103877 |
| 2015 |
TRIM-NHL proteins in development and disease. |
Seminars in cell & developmental biology |
81 |
26514622 |
| 2023 |
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study. |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
79 |
38072625 |
| 2020 |
RTEL1 suppresses G-quadruplex-associated R-loops at difficult-to-replicate loci in the human genome. |
Nature structural & molecular biology |
75 |
32398827 |
| 2014 |
The NHL domain of BRAT is an RNA-binding domain that directly contacts the hunchback mRNA for regulation. |
Genes & development |
71 |
24696456 |
| 2009 |
Ten years of rituximab in NHL. |
Expert opinion on drug safety |
70 |
19243307 |
| 2018 |
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. |
Annals of oncology : official journal of the European Society for Medical Oncology |
61 |
30060083 |
| 2019 |
Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes. |
The European respiratory journal |
57 |
30523160 |
| 2013 |
Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells. |
Nucleic acids research |
57 |
23470998 |
| 2015 |
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. |
American journal of epidemiology |
55 |
25713336 |
| 2008 |
The NHL-domain protein Wech is crucial for the integrin-cytoskeleton link. |
Nature cell biology |
50 |
18327251 |
| 2022 |
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL. |
Blood |
49 |
35439295 |
| 2020 |
RTEL1 Regulates G4/R-Loops to Avert Replication-Transcription Collisions. |
Cell reports |
48 |
33357438 |
| 2023 |
Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL. |
Blood advances |
47 |
36094847 |
| 2020 |
Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients. |
Journal for immunotherapy of cancer |
47 |
32152221 |
| 2009 |
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions. |
Clinical cancer research : an official journal of the American Association for Cancer Research |
47 |
19861448 |
| 2025 |
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial. |
Blood |
45 |
39792928 |
| 2021 |
RTEL1 influences the abundance and localization of TERRA RNA. |
Nature communications |
45 |
34021146 |
| 2017 |
Clinical and Molecular Heterogeneity of RTEL1 Deficiency. |
Frontiers in immunology |
44 |
28507545 |
| 2020 |
SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations. |
Nature structural & molecular biology |
42 |
32398829 |
| 2018 |
Evolutionary plasticity of the NHL domain underlies distinct solutions to RNA recognition. |
Nature communications |
38 |
29674686 |
| 2020 |
Human RTEL1 associates with Poldip3 to facilitate responses to replication stress and R-loop resolution. |
Genes & development |
37 |
32561545 |
| 2020 |
Molecular and biological functions of TRIM-NHL RNA-binding proteins. |
Wiley interdisciplinary reviews. RNA |
37 |
32738036 |
| 2019 |
Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies. |
British journal of haematology |
37 |
30613948 |
| 1995 |
Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin's lymphomas (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV. |
Leukemia & lymphoma |
36 |
8580826 |
| 2015 |
CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility. |
Carcinogenesis |
34 |
26014354 |
| 2004 |
[18F]3'-deoxy-3'-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations--a pilot study. |
Cancer biotherapy & radiopharmaceuticals |
34 |
15453958 |
| 2019 |
Helicases FANCJ, RTEL1 and BLM Act on Guanine Quadruplex DNA in Vivo. |
Genes |
32 |
31683575 |
| 2014 |
RTEL1 inhibits trinucleotide repeat expansions and fragility. |
Cell reports |
32 |
24561255 |
| 2021 |
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL. |
mAbs |
31 |
33818299 |
| 2020 |
Full length RTEL1 is required for the elongation of the single-stranded telomeric overhang by telomerase. |
Nucleic acids research |
31 |
32542379 |
| 2013 |
The C-terminal extension of human RTEL1, mutated in Hoyeraal-Hreidarsson syndrome, contains harmonin-N-like domains. |
Proteins |
31 |
24130156 |
| 2009 |
TRIM-NHL proteins take on miRNA regulation. |
Cell |
31 |
19269362 |
| 2013 |
RTEL1 tagging SNPs and haplotypes were associated with glioma development. |
Diagnostic pathology |
30 |
23683922 |
| 2016 |
Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. |
Journal of neuro-oncology |
29 |
26839018 |
| 2020 |
CD19-directed CAR T-cell therapy in B-cell NHL. |
Current opinion in oncology |
28 |
32740094 |
| 2017 |
Role of the microenvironment across histological subtypes of NHL. |
Hematology. American Society of Hematology. Education Program |
27 |
29222311 |
| 2011 |
Pathology, pathogenesis and molecular genetics of follicular NHL. |
Best practice & research. Clinical haematology |
26 |
21658611 |
| 2023 |
The many faces of the helicase RTEL1 at telomeres and beyond. |
Trends in cell biology |
25 |
37532653 |
| 2019 |
Roles of RAD51 and RTEL1 in telomere and rDNA stability in Physcomitrella patens. |
The Plant journal : for cell and molecular biology |
25 |
30834585 |
| 2013 |
Killing of CLL and NHL cells by rituximab and ofatumumab under limited availability of complement. |
Medical oncology (Northwood, London, England) |
25 |
24198205 |
| 2024 |
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy. |
Blood advances |
24 |
38531057 |
| 2023 |
Telomouse-a mouse model with human-length telomeres generated by a single amino acid change in RTEL1. |
Nature communications |
24 |
37872177 |
| 2012 |
Generation of a mouse model for studying the role of upregulated RTEL1 activity in tumorigenesis. |
Transgenic research |
24 |
22238064 |
| 2020 |
An RTEL1 Mutation Links to Infantile-Onset Ulcerative Colitis and Severe Immunodeficiency. |
Journal of clinical immunology |
23 |
32710398 |
| 2018 |
Human RTEL1 stabilizes long G-overhangs allowing telomerase-dependent over-extension. |
Nucleic acids research |
23 |
29522136 |
| 2023 |
RTEL1 and MCM10 overcome topological stress during vertebrate replication termination. |
Cell reports |
22 |
36807139 |
| 2021 |
TRIM-NHL as RNA Binding Ubiquitin E3 Ligase (RBUL): Implication in development and disease pathogenesis. |
Biochimica et biophysica acta. Molecular basis of disease |
22 |
33418035 |
| 2018 |
NHL in adolescents and young adults: A unique population. |
Pediatric blood & cancer |
22 |
29741220 |
| 2016 |
Extended clinical and genetic spectrum associated with biallelic RTEL1 mutations. |
Blood advances |
22 |
29296694 |
| 2015 |
Human regulator of telomere elongation helicase 1 (RTEL1) is required for the nuclear and cytoplasmic trafficking of pre-U2 RNA. |
Nucleic acids research |
22 |
25628358 |
| 2015 |
Analysis of difference of association between polymorphisms in the XRCC5, RPA3 and RTEL1 genes and glioma, astrocytoma and glioblastoma. |
American journal of cancer research |
22 |
26328260 |
| 2023 |
PI3k Inhibitors in NHL and CLL: An Unfulfilled Promise. |
Blood and lymphatic cancer : targets and therapy |
19 |
36919100 |
| 2018 |
RAD51 and RTEL1 compensate telomere loss in the absence of telomerase. |
Nucleic acids research |
19 |
29346668 |
| 2007 |
Should adolescents with NHL be treated as old children or young adults? |
Hematology. American Society of Hematology. Education Program |
19 |
18024643 |
| 2002 |
Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL. |
Cytotherapy |
19 |
12194721 |
| 2023 |
CSNK2 suppresses autophagy by activating FLN-NHL-containing TRIM proteins. |
Autophagy |
18 |
37938186 |
| 2022 |
Herbicide use in farming and other jobs in relation to non-Hodgkin's lymphoma (NHL) risk. |
Occupational and environmental medicine |
17 |
36207110 |
| 2015 |
Associations between statin use and non-Hodgkin lymphoma (NHL) risk and survival: a meta-analysis. |
Hematological oncology |
17 |
26482323 |
| 2014 |
Carrier screening of RTEL1 mutations in the Ashkenazi Jewish population. |
Clinical genetics |
17 |
25047097 |
| 2023 |
Simultaneous activation of Tor and suppression of ribosome biogenesis by TRIM-NHL proteins promotes terminal differentiation. |
Cell reports |
16 |
36870055 |
| 2022 |
Clinical characteristics and outcomes of newly diagnosed patients with HIV-associated aggressive B-cell NHL in China. |
Journal of cellular and molecular medicine |
16 |
36056692 |
| 2020 |
WD40 protein Wuho controls germline homeostasis via TRIM-NHL tumor suppressor Mei-p26 in Drosophila. |
Development (Cambridge, England) |
16 |
31941704 |
| 2022 |
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL). |
Current treatment options in oncology |
15 |
35258793 |
| 2003 |
The role of nuclear medicine in the treatment of non-Hodgkin's lymphoma (NHL). |
Leukemia & lymphoma |
15 |
15154740 |
| 2015 |
Association between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control Study. |
Medical science monitor : international medical journal of experimental and clinical research |
14 |
26156397 |
| 2013 |
Relapsed and refractory aggressive NHL: time for a change. |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis |
14 |
23835116 |
| 2003 |
Radioimmunotherapy for NHL: experience of 90Y-ibritumomab tiuxetan in clinical practice. |
Leukemia & lymphoma |
14 |
15154741 |
| 2002 |
Autologous and allogeneic transplantation for aggressive NHL. |
Cytotherapy |
14 |
12194719 |
| 2017 |
Association between regulator of telomere elongation helicase1 (RTEL1) gene and HAPE risk: A case-control study. |
Medicine |
13 |
28953687 |
| 2015 |
B-cell receptor pathway modulators in NHL. |
Hematology. American Society of Hematology. Education Program |
13 |
26637705 |
| 2024 |
FNC (4'-azido-2'-deoxy-2'-fluoro(arbino)cytidine) as an Effective Therapeutic Agent for NHL: ROS Generation, Cell Cycle Arrest, and Mitochondrial-Mediated Apoptosis. |
Cell biochemistry and biophysics |
12 |
38253918 |
| 2021 |
KLF4 inhibition by Kenpaullone induces cytotoxicity and chemo sensitization in B-NHL cell lines via YY1 independent. |
Leukemia & lymphoma |
12 |
33410342 |